Universal Health (UHS) Fundamental Analysis: Revenue, Earnings & Valuation

5.69 / 10

Netural

Fundamental analysis scores 5.7/10, indicating average quality. Strong cash‑to‑market (Cash‑MV) and revenue‑to‑market metrics boost the profile, while cash growth (Cash‑UP) and total profit YoY lag. EPS growth is robust, but overall fundamentals remain neutral.

Analysis Checks(6/10)

Revenue-MV

Value1.20

Score2/3

Weight13.66%

1M Return3.89%

Net cash flow from operating activities per share (YoY growth rate %)

Value-4.03

Score1/3

Weight6.68%

1M Return2.13%

Inventory turnover ratio

Value7.32

Score2/3

Weight5.53%

1M Return1.88%

Net income-Revenue

Value0.03

Score3/3

Weight29.22%

1M Return7.62%

Basic earnings per share (YoY growth rate %)

Value36.48

Score2/3

Weight4.83%

1M Return1.62%

Total profit (YoY growth rate %)

Value31.66

Score1/3

Weight6.15%

1M Return1.97%

Net cash flow from operating activities (YoY growth rate %)

Value-9.81

Score1/3

Weight5.00%

1M Return1.69%

Cash-UP

Value0.33

Score0/3

Weight-7.22%

1M Return-2.65%

Diluted earnings per share (YoY growth rate %)

Value37.34

Score2/3

Weight4.74%

1M Return1.55%

Cash-MV

Value0.61

Score3/3

Weight31.41%

1M Return8.03%

Is UHS undervalued or overvalued?

UHS scores 5.69/10 on fundamentals and holds a Fair valuation at present. Backed by its 21.01% ROE, 8.70% net margin, 7.66 P/E ratio, 1.54 P/B ratio, and 36.48% earnings growth, these metrics solidify its Netural investment rating.